{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:25:57Z","timestamp":1781785557690,"version":"3.54.5"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.neuropharm.2012.04.031","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T12:29:04Z","timestamp":1336652944000},"page":"547-554","source":"Crossref","is-referenced-by-count":18,"title":["Region-specific elevation of D1 receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit\/hyperactivity disorder"],"prefix":"10.1016","volume":"63","author":[{"given":"Yukihiro","family":"Ohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junta","family":"Imaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Tatara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.04.031_bib1","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1073\/pnas.94.22.12157","article-title":"Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice","volume":"94","author":"Adams","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.neuroscience.2010.06.029","article-title":"Chronic low dose Adderall XR down-regulates cfos expression in infantile and prepubertal rat striatum and cortex","volume":"169","author":"Allen","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.12.083","article-title":"Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum","volume":"1318","author":"Beauvais","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib5","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1523\/JNEUROSCI.1039-08.2008","article-title":"Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol","volume":"28","author":"Bertran-Gonzalez","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1460-9568.2003.02520.x","article-title":"Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex","volume":"17","author":"Blandini","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neubiorev.2003.08.008","article-title":"Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in\u00a0vivo microdyalisis study","volume":"27","author":"Carboni","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.devbrainres.2005.04.003","article-title":"Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum","volume":"157","author":"Chase","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib9","first-page":"299","article-title":"Fos, nociception and the dorsal horn","volume":"77","author":"Coggeshall","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib10","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","article-title":"The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder","volume":"69","author":"Del Campo","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1744-9081-2-18","article-title":"Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats","volume":"2","author":"Diaz Heijtz","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib12","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","article-title":"DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study","volume":"18","author":"Ernst","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1744-9081-2-40","article-title":"Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder","volume":"2","author":"Forssberg","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(97)00793-2","article-title":"Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I","volume":"771","author":"Gattu","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1586\/ern.10.17","article-title":"Attention-deficit\/hyperactivity disorder and the dopaminergic hypotheses","volume":"10","author":"Genro","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.1976.01770100079008","article-title":"Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results","volume":"33","author":"Gittelman-Klein","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib19","article-title":"Using spatial multiple regression to identify intrinsic connectivity networks involved in working memory performance","author":"Gordon","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2008.03.016","article-title":"New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD","volume":"90","author":"Heal","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0031-9384(85)90199-4","article-title":"Age, sex and strain differences in activity and habituation in SHR and WKY rats","volume":"34","author":"Hendley","year":"1985","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(96)00021-4","article-title":"Activation of c-fos in the brain","volume":"50","author":"Herrera","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00247-6","article-title":"Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1\/D2 agonists","volume":"113","author":"Ikemoto","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(99)00015-5","article-title":"Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain","volume":"63","author":"Ishibashi","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0022-3565(25)12900-5","article-title":"Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum","volume":"277","author":"Johnson","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1037\/0735-7044.122.2.340","article-title":"Advancing the spontaneous hypertensive rat model of attention deficit\/hyperactivity disorder","volume":"122","author":"Kantak","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0163-1047(84)90376-5","article-title":"Passive-avoidance behavior of spontaneously hypertensive rats","volume":"42","author":"Knardahl","year":"1984","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1385\/NMM:8:4:461","article-title":"Attention deficit hyperactivity disorder","volume":"8","author":"Kuntsi","year":"2006","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neubiorev.2003.08.009","article-title":"Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD","volume":"27","author":"Leo","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02244872","article-title":"Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions","volume":"116","author":"Maldonado-Irizarry","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib31","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1073\/pnas.90.8.3447","article-title":"Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics","volume":"90","author":"Marchant","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/102538902900012369","article-title":"Mapping brain response to social stress in rodents with c-fos expression: a review","volume":"5","author":"Martinez","year":"2002","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s002130050921","article-title":"Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats","volume":"143","author":"Mayorga","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1441.016","article-title":"ADHD and smoking: from genes to brain to behavior","volume":"1141","author":"McClernon","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib35","first-page":"971","article-title":"Brain monoamines and metabolites in hypertensive and hyperactive rat strains","volume":"10","author":"McKeon","year":"1988","journal-title":"Clin. Exp. Hypertens. A"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib36","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/00001756-200008030-00010","article-title":"Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine","volume":"11","author":"Miwa","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0166-2236(89)90096-9","article-title":"Stimulus-transription coupling in neuron: role of cellular immediate-early genes","volume":"12","author":"Morgan","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuropharm.2008.06.005","article-title":"Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens","volume":"55","author":"Ohno","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2009.07.012","article-title":"Regional expression of Fos-like immunoreactivity following seizures in Noda Epileptic Rat (NER)","volume":"87","author":"Ohno","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1254\/jphs.08313FP","article-title":"Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice","volume":"109","author":"Ohno","year":"2009","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pbb.2010.04.027","article-title":"Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist","volume":"96","author":"Ohno","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nbd.2010.09.013","article-title":"Scn1a missense mutation causes limbic hyperexcitability and vulnerability to experimental febrile seizures","volume":"41","author":"Ohno","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tips.2008.01.002","article-title":"The neuropharmacology of impulsive behaviour","volume":"29","author":"Pattij","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib44","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib45","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ajmg.b.31070","article-title":"Intra-individual variability in genetic and environmental models of attention-deficit\/hyperactivity disorders","volume":"153B","author":"Perry","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0022-3565(25)12090-9","article-title":"Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine","volume":"275","author":"Pierce","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.biopsych.2004.08.026","article-title":"The neuropsychopharmacology of attention-deficit\/hyper- activity disorder","volume":"57","author":"Pliszka","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.npp.1300643","article-title":"The effects of temporary inactivation of the core and the shell subregions of the nucleus accumbens on prepulse inhibition of the acoustic startle reflex and activity in rats","volume":"30","author":"Pothuizen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(94)91977-1","article-title":"Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat","volume":"664","author":"Pulvirenti","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib50","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neubiorev.2003.08.010","article-title":"Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder \u2013 the spontaneously hypertensive rat","volume":"27","author":"Russell","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1023819220840","article-title":"In\u00a0vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats","volume":"18","author":"Russell","year":"2003","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0149-7634(99)00057-3","article-title":"Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit","volume":"24","author":"Sadile","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","article-title":"Behavioral validation of the spontaneously hypertensive rats (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD)","volume":"24","author":"Sagvolden","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib55","series-title":"Stimulant Drugs and ADHD Basic and Clinical Neuroscience","first-page":"221","article-title":"The spontaneously hypertensive rat as a model of ADHD","author":"Sagvolden","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib56","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.biopsych.2005.02.002","article-title":"Rodent models of attention-deficit\/hyperactivity disorder","volume":"57","author":"Sagvolden","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuropharm.2009.08.004","article-title":"The spontaneously hypertensive rat model of ADHD\u2013the importance of selecting the appropriate reference strain","volume":"57","author":"Sagvolden","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/7854_2011_126","article-title":"Rat models of ADHD","volume":"9","author":"Sagvolden","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib59","series-title":"Stimulant Drugs and ADHD Basic and Clinical Neuroscience","first-page":"3","article-title":"Attention-deficit\/hyperactivity disorder: clinical features","author":"Solanto","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib60","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.neuroimage.2009.12.104","article-title":"Neural response to working memory load varies by dopamine transporter genotype in children","volume":"53","author":"Stollstorff","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/h0077649","article-title":"Two-way shuttle box and lever-press avoidance in the spontaneously hypertensive and normotensive rat","volume":"94","author":"Sutterer","year":"1980","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib62","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0091-3057(97)00043-9","article-title":"Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat","volume":"58","author":"Swanson","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(77)90122-4","article-title":"Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats","volume":"43","author":"Tilson","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200202000-00001","article-title":"Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder","volume":"13","author":"Ueno","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.302.1.95","article-title":"Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder","volume":"302","author":"Ueno","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neubiorev.2003.08.011","article-title":"Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder","volume":"27","author":"Viggiano","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1155\/NP.2004.97","article-title":"Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling","volume":"11","author":"Viggiano","year":"2004","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib68","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib69","first-page":"470","article-title":"Brain dopamine transporter in spontaneously hypertensive rats","volume":"38","author":"Watanabe","year":"1997","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archpsyc.1975.01760240118009","article-title":"Methylphenidate and haloperidol in children. Effects on attention, memory, and activity","volume":"32","author":"Werry","year":"1975","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.031_bib71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.med.53.082901.103945","article-title":"Attention deficit\/hyperactivity disorder across the lifespan","volume":"53","author":"Wilens","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.1999.tb09264.x","article-title":"Functional\u2013anatomical implications of the nucleus accumbens core and shell subterritories","volume":"877","author":"Zahm","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1369.001","article-title":"Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors","volume":"1074","author":"Zhang","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.031_bib74","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1523\/JNEUROSCI.3795-06.2006","article-title":"c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes","volume":"26","author":"Zhang","year":"2006","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:47:46Z","timestamp":1743101266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0028390812001670"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}